| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.67M | 6.07M | 5.63M | 5.74M | 5.40M | 6.04M |
| Gross Profit | 3.38M | 2.58M | 2.16M | 2.18M | 2.01M | 2.37M |
| EBITDA | 1.99M | 1.30M | 716.06K | 700.12K | 1.25M | 875.70K |
| Net Income | 1.45M | 883.58K | 767.93K | 492.89K | 995.02K | 549.57K |
Balance Sheet | ||||||
| Total Assets | 67.72K | 12.43M | 11.82M | 12.05M | 11.33M | 11.11M |
| Cash, Cash Equivalents and Short-Term Investments | 2.18M | 11.10M | 10.44M | 10.78M | 10.09M | 9.50M |
| Total Debt | 0.00 | 35.30K | 56.49K | 50.14K | 70.37K | 769.98K |
| Total Liabilities | 453.41K | 745.60K | 1.02M | 735.07K | 508.46K | 1.28M |
| Stockholders Equity | 12.84M | 11.69M | 10.80M | 11.32M | 10.82M | 9.83M |
Cash Flow | ||||||
| Free Cash Flow | 1.29M | 665.95K | 914.84K | 672.37K | 368.01K | 933.59K |
| Operating Cash Flow | 1.31M | 675.08K | 932.36K | 711.24K | 386.39K | 987.44K |
| Investing Cash Flow | -1.62M | -1.13M | 806.79K | -8.76M | -18.38K | -53.85K |
| Financing Cash Flow | 13.40K | 35.30K | -1.21M | 0.00 | 218.90K | 460.70K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | $14.72M | 10.52 | 11.75% | ― | 8.72% | 66.72% | |
61 Neutral | $7.62B | 9.19 | 19.71% | ― | 13.71% | -18.02% | |
59 Neutral | $3.85B | ― | -15.06% | ― | 47.39% | 85.35% | |
58 Neutral | $19.40B | ― | -21.93% | ― | 14.92% | -286.72% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
50 Neutral | $1.27B | -21.16 | -16.90% | ― | 15.23% | 38.79% | |
45 Neutral | $4.81B | -16.15 | -22.32% | ― | 37.38% | -912.18% |
On September 16, 2025, Pacific Health Care Organization, Inc.’s subsidiaries, Medex Healthcare, Inc. and Medex Medical Management, Inc., filed lawsuits in California’s Superior Court against former executives David Kim and Darshan Patel, respectively. The lawsuits allege multiple breaches, including contract violations and misappropriation of trade secrets, seeking damages exceeding $1 million, along with other legal remedies, which could significantly impact the company’s operations and stakeholder interests.